Smoking increases risk of recurrence after successful anti-tuberculosis treatment: A population-based study

International Journal of Tuberculosis and Lung Disease

Volumn 18, Issue 4, 2014, Pages 492-498

  Yen, Y F ^a,b   Yen, M Y ^a   Lin, Y S ^c   Lin, Y P ^a   Shih, H C ^a   Li, L H ^a   Chou, P ^b   Deng, Chung Yeh ^b  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Recurrence; Smoking; Taiwan; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ACID FAST BACILLI; ACID FAST BACTERIUM; ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RECURRENCE RISK; SMOKING; SMOKING CESSATION PROGRAM; TAIWAN; TREATMENT RESPONSE; TUBERCULOSIS; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION; YOUNG ADULT; ADOLESCENT; EPIDEMIOLOGY; KAPLAN MEIER METHOD; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SMOKING; TAIWAN; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84897141176     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.13.0694     Document Type: Article

References (35)

1. Panjabi R, Comstock G W, Golub J E. Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk. Int J Tuberc Lung Dis 2007; 11: 828-837. (Pubitemid 47227613)
2. Yu C C, Chang C Y, Liu C E, Shih L F, Hsiao J H, Chen C H. Drug resistance pattern of Mycobacterium tuberculosis complex at a medical center in central Taiwan, 2003-2007. J Microbiol Immunol Infect 2010; 43: 285-290.
3. El Sahly H M, Wright J A, Soini H, et al. Recurrent tuberculosis in Houston, Texas: a population-based study. Int J Tuberc Lung Dis 2004; 8: 333-340. (Pubitemid 38624870)
4. Murray J, Sonnenberg P, Shearer S C, Godfrey-Faussett P. Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients. Am J Respir Crit Care Med 1999; 159: 733-740. (Pubitemid 29137767)
5. Slama K, Chiang C Y, Enarson D A, et al. Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis 2007; 11: 1049-1061. (Pubitemid 47605393)
6. BatesMN, Khalakdina A, Pai M, Chang L, Lessa F, Smith K R. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med 2007; 167: 335-342. (Pubitemid 46333932)
7. Lin H H, Ezzati M, Murray M. Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLOS Med 2007; 4: e20.
8. Thomas A, Gopi P G, Santha T, et al. Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India. Int J Tuberc Lung Dis 2005; 9: 556-561. (Pubitemid 40646843)
9. Jee S H, Golub J E, Jo J, Park I S, Ohrr H, Samet J M. Smoking and risk of tuberculosis incidence, mortality, and recurrence in South Korean men and women. Am J Epidemiol 2009; 170: 1478-1485.
10. d'Arc Lyra Batista J, de Fatima Pessoa Militao de Albuquerque M, de Alencar Ximenes R A, Rodrigues L C. Smoking increases the risk of relapse after successful tuberculosis treatment. Int J Epidemiol 2008; 37: 841-851.
11. Millet J P, Orcau A, de Olalla P G, Casals M, Rius C, Cayla J A. Tuberculosis recurrence and its associated risk factors among successfully treated patients. J Epidemiol Community Health 2009; 63: 799-804.
12. World Health Organization: Global tuberculosis control.WHO Report 1999. WHO/CDS/CPC/TB/99.259. Geneva, Switzerland: WHO, 1999.
13. Wang F D, Chang C H, Su W J, et al. Screening of hospital workers for pulmonary tuberculosis in a medical center in Taiwan. Infect Control Hosp Epidemiol 2006; 27: 510-511.
14. Lai C C, Wang H C. Diagnostic performance of enzyme-linked immunospot assay and whole-blood interferon-gamma assay for the diagnosis of extrapulmonary tuberculosis. J Microbiol Immunol Infect 2011; 44: 406-407.
15. American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society of America. Treatment of tuberculosis.MMWR Recomm Rep 2003; 52 (RR-11): 1-77.
16. Taiwan Centers for Disease Control and Prevention. Surveillance and statistics of reportable infectious diseases. Taipei, Taiwan: Taiwan CDC, 2004. http://203.65.72.83/ch/dt/upload/QC/QC-index.htm Accessed January 2014.
17. van Rie A, Warren R, Richardson M, et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med 1999; 341: 1174-1179. (Pubitemid 29480655)
18. Cacho J, Perez Meixeira A, Cano I, et al. Recurrent tuberculosis from 1992 to 2004 in a metropolitan area. Eur Respir J 2007; 30: 333-337. (Pubitemid 47194186)
19. Singapore Tuberculosis Service/British Medical Research Council. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Am Rev Respir Dis 1991; 143: 707-712.
20. Snider D E, Graczyk J, Bek E, Rogowski J. Supervised sixmonths' treatment of newly diagnosed pulmonary tuberculosis using isoniazid, rifampin, and pyrazinamide with and without streptomycin. Am Rev Respir Dis 1984; 130: 1091-1094. (Pubitemid 15186171)
21. Wang J Y, Lee L N, Lai H C, et al. Prediction of the tuberculosis reinfection proportion from the local incidence. J Infect Dis 2007; 196: 281-288.
22. Shen G, Xue Z, Shen X, et al. The study recurrent tuberculosis and exogenous reinfection, Shanghai, China. Emerg Infect Dis 2006; 12: 1776-1778. (Pubitemid 44674261)
23. World Health Organization. Global tuberculosis control, 2011. Geneva, Switzerland: WHO, 2011. WHO/HTM/TB/2011.16. http://whqlibdoc.who.int/ publications/2011/9789241564380-eng.pdf. Accessed January 2014.
24. Brewer T F, Heymann S J. To control and beyond: moving towards eliminating the global tuberculosis threat. J Epidemiol Community Health 2004; 58: 822-825. (Pubitemid 39279740)
25. Secades-Villa R, Alonso-Perez F, Garcia-Rodriguez O, Fernandez-Hermida J R. Effectiveness of three intensities of smoking cessation treatment in primary care. Psychol Rep 2009; 105: 747-758.
26. Sereno A B, Soares E C, Lapa E S J R, et al. Feasibility study of a smoking cessation intervention in directly observed therapy short-course tuberculosis treatment clinics in Rio de Janeiro, Brazil. Rev Panam Salud Publica 2012; 32: 451-456.
27. Lin H H, Ezzati M, Chang H Y, Murray M. Association between tobacco smoking and active tuberculosis in Taiwan: prospective cohort study. Am J Respir Crit Care Med 2009; 180: 475-480.
28. Boelaert J R, Gomes M S, Gordeuk V R. Smoking, iron and tuberculosis. Lancet 2003; 362: 1243-1244.
29. Davies P D, Yew W W, Ganguly D, et al. Smoking and tuberculosis: the epidemiological association and immunopathogenesis. Trans R Soc Trop Med Hyg 2006; 100: 291-298. (Pubitemid 43174829)
30. Beijer U, Wolf A, Fazel S. Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12: 859-870.
31. Burman W J, Cohn D L, Rietmeijer C A, Judson F N, Sbarbaro J A, Reves R R. Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment. Chest 1997; 111: 1168-1173. (Pubitemid 27200067)
32. Story A, van Hest R, Hayward A. Tuberculosis and social exclusion. BMJ 2006; 333: 57-58. (Pubitemid 44406808)
33. British Thoracic Association. A controlled trial of six months' chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. Am Rev Respir Dis 1982; 126: 460-462.
34. Yamagishi F, Toyota M. [Research and control of relapse tuberculosis cases]. Kekkaku 2009; 84: 767-768. [Japanese]
35. Benator D, Bhattacharya M, Bozeman L, et al. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial. Lancet 2002; 360: 528-534.